Our previous study investigated the prevalence of anti-PTX3 antibodies in a cohort of patients with various rheumatic musculoskeletal diseases, including ACPA-positive RA patients, as well as healthy and disease controls [10]. The gene discussed is PTX3; the disease is rheumatoid arthritis.